Lipid-regulators and myopathy, rhabdomyolysis
Bao Wu
Abstract
Bao Wu
Abstract
It is reported that lipid-regulators including statins, nicotinic acid and fibrates can induce severe adverse reactions such as myopathy, even rhabdomyolysis which endangers the patient's life. The authors have discussed the relationship between lipid-regulators and myopathy, rhabdomyolysis, how those drugs cause these adverse reactions and the major factors for myopathy and rhabdomyolysis in order to deepen the knowledge, prevent the happenness of these diseases and develop the more effective and safer lipid-regulators.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
It is reported that lipid-regulators including statins, nicotinic acid and fibrates can induce severe adverse reactions such as myopathy, even rhabdomyolysis which endangers the patient's life. The authors have discussed the relationship between lipid-regulators and myopathy, rhabdomyolysis, how those drugs cause these adverse reactions and the major factors for myopathy and rhabdomyolysis in order to deepen the knowledge, prevent the happenness of these diseases and develop the more effective and safer lipid-regulators.
Key concepts: Rhabdomyolysis, Myopathy, Medicine, Pharmacology, Intensive care medicine, Internal medicine